NCT03495934View on ClinicalTrials.gov

A Study In Healthy Male Volunteers Designed To Investigate How A Radiolabelled Medicine Is Broken Down And Removed From The Body

PHASE1CompletedINTERVENTIONAL
Enrollment

6

Participants

Timeline

Start Date

February 8, 2018

Primary Completion Date

February 28, 2018

Study Completion Date

February 28, 2018

Conditions
Healthy Subjects
Interventions
DRUG

pracinostat

\[14C\]-pracinostat

Trial Locations (1)

NG116JS

Quotient Science, Ruddington

Sponsors
All Listed Sponsors
collaborator

Quotient Sciences

INDUSTRY

lead

Helsinn Healthcare SA

INDUSTRY